Twist Bioscience Corp (TWST)
41.21
+9.20
(+28.74%)
USD |
NASDAQ |
May 03, 16:00
41.18
-0.03
(-0.07%)
After-Hours: 20:00
Twist Bioscience Cash from Investing (Quarterly): -5.24M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.24M |
| December 31, 2023 | 4.165M |
| September 30, 2023 | -2.247M |
| June 30, 2023 | 18.67M |
| March 31, 2023 | 41.16M |
| December 31, 2022 | -6.971M |
| September 30, 2022 | 2.783M |
| June 30, 2022 | 4.163M |
| March 31, 2022 | -13.29M |
| December 31, 2021 | -226.58M |
| September 30, 2021 | 23.91M |
| June 30, 2021 | 104.58M |
| March 31, 2021 | 73.59M |
| Date | Value |
|---|---|
| December 31, 2020 | -45.92M |
| September 30, 2020 | -94.67M |
| June 30, 2020 | -61.15M |
| March 31, 2020 | 28.76M |
| December 31, 2019 | 12.40M |
| September 30, 2019 | -1.187M |
| June 30, 2019 | -22.71M |
| March 31, 2019 | -15.16M |
| December 31, 2018 | -65.76M |
| September 30, 2018 | 0.404M |
| June 30, 2018 | 4.58M |
| March 31, 2018 | 14.11M |
| December 31, 2017 | 8.215M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-226.58M
Minimum
Dec 2021
104.58M
Maximum
Jun 2021
-8.289M
Average
0.798M
Median
Cash from Investing (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | -16.58M |
| Perspective Therapeutics Inc | -0.089M |
| Xtant Medical Holdings Inc | -2.313M |
| Asensus Surgical Inc | 7.427M |
| Catheter Precision Inc | -0.018M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.42M |
| Cash from Financing (Quarterly) | 1.828M |
| Free Cash Flow | -95.52M |
| Free Cash Flow Per Share (Quarterly) | -0.3466 |
| Free Cash Flow to Equity (Quarterly) | -20.03M |
| Free Cash Flow to Firm (Quarterly) | -20.03M |
| Free Cash Flow Yield | -4.04% |